Last reviewed · How we verify
NCT03668964: VitaGut
Effect of Nutrition Ingredients on Microbiota Modulation
NA trial testing Vitamin B2 in Healthy Volunteers in 96 participants. Completed in 15 July 2019.
15 July 2019
Quick facts
| Lead sponsor | dsm-firmenich Switzerland AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 96 |
| Start date | 20 August 2018 |
| Primary completion | 15 July 2019 |
| Estimated completion | 15 July 2019 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- Vitamin B2
- Vitamin C — full drug profile →
- Vitamin B2 + C
- Vitamin A — full drug profile →
- Vitamin D3 (cholecalciferol) — full drug profile →
- Vitamin E (VITAMIN E) — full drug profile →
- Placebo
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
dsm-firmenich Switzerland AG — full company profile →
Who can join
Adults 20 to 50, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate in healthy volunteers the time-dependent effect of daily consumption for four weeks of six different nutrition ingredients on relative abundance of microbial taxa in fecal samples. Second, the study looks at the time-dependent effect of six different nutrition ingredients on alpha and beta diversity of microbiota in fecal samples. Moreover, the time-dependent effect of six different nutrition ingredients on gastrointestinal symptoms and quality of life will be measured.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study.
Pham VT, Fehlbaum S, Seifert N, Richard N, et al · · 2021 · cited 106× · PMID 33615992 · DOI 10.1080/19490976.2021.1875774
Verify or expand the search:
- PubMed search for NCT03668964
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other dsm-firmenich Switzerland AG trials
Trials by the same sponsor.
- NCT06889779 — Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms · NA · recruiting
- NCT06425081 — Investigating the Impact of Humiome B2 (Colon Delivered Riboflavin) and Riboflavin-overproducer Probiotic Strain Limosil · NA · completed
- NCT06578455 — A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions · Phase 1 · completed
- NCT06471023 — A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms · NA · completed
- NCT05205785 — Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS) · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03668964 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by dsm-firmenich Switzerland AG
- Last refreshed: 30 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03668964.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing